Kalorama: Need for Biopharmaceuticals Driving Cell Culture Supply Market

NEW YORK, June 29, 2015 /PRNewswire/ -- Research firm Kalorama Information says that growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market.  Worldwide sales are estimated to have exceeded $3.4 billion in 2014, up 8.1% from 2013 sales of $3.1 billion.  The finding was made in Kalorama Information's report, Cell Culture: The Market for Sera, Media and Reagents. 

The report can be obtained from Kalorama Information at: http://www.kaloramainformation.com/redirect.asp?progid=87571&productid=9022143.  In it, Kalorama says that the new types of therapies demanded by patients and providers will require cell culture to grow. 

"In order to manufacture biologic drugs, cell culture is essential," said Bruce Carlson, Publisher of Kalorama Information.  "As our report indicates there is a significant market for media, sera and reagents and growth last year was significant."

Kalorama says that the growing demand for biopharmaceuticals stems from the demonstrable ability of biologicals to address unmet medical needs. Biological products are developed from large and complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. Protein-based biopharmaceuticals are invariably produced by an initial cell culture step (upstream processing), followed by product recovery, purification and formulation into final product format (downstream processing). Upstream processing, the development phase of biopharmaceuticals, is slow, expensive and complicated, and frequently leads to a bottleneck in getting new products to the clinic.

Different kinds of cells require different types of media. Serum based media are widely used to grow a broad range of animal cell types and cell lines such as Chinese hamster ovaries (CHO) or murine myeloma cells (NS0) cells. The most common media used for microorganisms, primarily used for the growth of bacteria, is Lysogeny broth (LB), a nutritionally rich medium. It is also known as Luria broth or Luria-Bertani broth.  The primary distinction in the types of media is that made between media required for animal cells and media required for microorganisms, such as bacteria or yeast. 

The cell culture market will continue to be strengthened by biomedical research.  In cell biology research, cell screening technology has proved to be very important in finding high-producing cell lines, and research is now focused on how to predict growth characteristics of cells at an earlier stage.  Progress in the future will come from processes, such as metabolic engineering, that will aid in improving cell lines.

"Going forward, improving cell lines will continue to be a main focal point of research," said Carlson.  "Biomedical research and bioprocessing have a wide range of supply needs, including high quality media and reagents for fermentation and cell culture. "

Kalorama Information's report breaks out the different types of cell culture media with forecasts and numbers. It also breaks out bovine and other sera, and groups reagents by their function.  For more information or to order Cell Culture: The Market for Sera, Media and Reagents, visit http://www.kaloramainformation.com/redirect.asp?progid=87571&productid=9022143.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.  

Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com

Logo - http://photos.prnewswire.com/prnh/20140801/132634

SOURCE Kalorama Information